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Peripheral arterial disease increases the risk of multidrug-resistant bacteria and
amputation in diabetic foot infections
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Background/aim: The aim of this study was to investigate the microbiological profile and resistance rates of diabetic foot infections
(DFIs) and to determine the effect of peripheral arterial disease (PAD) on the microbiology, clinical condition, and treatment outcomes.
Materials and methods: Characteristics, laboratory and imaging data, and the treatment modalities of patients admitted to our hospital
with a diagnosis of DFI (PEDIS classification 3–4) during 2005–2016 were analyzed according to the presence of PAD.
Results: Of 112 patients who were included in this study, 86 (76.8%) had PAD. Patients with PAD were older and had higher amputation
rates (P < 0.05). A microbiological profile of patients revealed a predominance of gram-positive bacteria (57.1%). Staphylococcus aureus
and Streptococcus spp. were the most frequently encountered bacteria. Incidence of Pseudomonas spp. infection was higher in the PAD
group (P < 0.05). Of all patients, 24.1% had multidrug-resistant (MDR) microorganisms in their wound cultures. Presence of MDR
bacteria in patients with PAD was 4.9-fold higher than that in patients without PAD (P < 0.05).
Conclusion: This retrospective study indicates that PAD has a significant role, especially in elderly patients with DFIs. Patients should
be promptly evaluated and treated for PAD to prevent infections with resistant microorganisms and limb loss.
Key words: Diabetic foot, peripheral arterial disease, infection

1. Introduction
Approximately one-fourth of diabetic patients experience
lower extremity infections in their lifetime, and 15%–20%
of these infections result in amputation (1,2). Diabetic foot
infections (DFIs) are also the most common complication
in diabetic patients, which lead to hospitalization (3). The
major risk factors for the development of DFIs include
peripheral arterial disease (PAD), neuropathy, and poor
glycemic control (4). PAD, defined as an occlusion of the
lower extremity arteries, has a special place among these
risk factors (5). In diabetic patients with PAD, changes in
the peripheral vascular bed lead to hypoxia in the tissue
and also cause decreased antibiotic concentrations at the
infection site. Consequently, the wound healing process is
impaired, treatment becomes more difficult, and the rates
of amputation and mortality increase (4,6,7).
Staphylococcus aureus and beta-hemolytic streptococci
are the most frequent pathogens in DFIs. These
microorganisms are particularly isolated in patients who
do not have vascular pathology and antibiotic exposure.

Gram-negative bacteria and anaerobes are more common
in patients with long-term lesions and severe ischemia
(8). Pseudomonas is often isolated in patients living in
warm-climate regions such as Turkey (7). The prevalence
of multidrug-resistant (MDR) organisms in patients
with DFIs increases constantly due to inappropriate
use of antibiotics. The treatment of these patients becomes
challenging, hospital admission becomes prolonged, and
treatment cost and mortality rates increase (2,9).
The aims of this study were to investigate the
microbiological profile and the resistance rates of DFIs
and to determine the effect of PAD on the microbiology,
clinical condition, and treatment outcomes.
2. Materials and methods
Medical records of patients admitted to our hospital with
a diagnosis of DFI during 2005–2016 were retrospectively
reviewed from patient files and the hospital information
management system. DFIs were classified using the
PEDIS infection score system (7). Patients with grades 3
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and 4 PEDIS infection scores and those having positive
culture results were included in the study. Wound
cultures were collected as aerobic deep tissue specimens.
Patient characteristics, laboratory and imaging data, and
treatment modalities were reviewed. The presence of PAD
was evaluated according to Doppler ultrasound and, in
some cases, lower extremity angiography results. Patients
who had stenosis with velocity changes (velocity increase,
monophasic/biphasic flow, or collateral flow) in Doppler
ultrasound were interpreted as having PAD (10). Patients
who had stenotic segments in DSA imaging were also
evaluated as having PAD. The diagnosis of osteomyelitis
was established by plain radiography and magnetic
resonance imaging findings. A minor lower extremity
amputation was defined as any amputation distal to the
ankle joint, while a major amputation was any amputation
through or proximal to the ankle joint (11). The definition
of MDR bacteria was made according to the criteria
described by the CDC and the ECDC (12).
Statistical analysis was performed using SPSS 20.
Qualitative variables were expressed as percentage, while
quantitative variables were expressed as mean (±standard
deviation) and median (range). Comparisons between
groups were made using the chi-square test for categorical
variables and the Mann–Whitney U test for numeric
variables. Statistical significance was defined P < 0.05.
Odds ratios (ORs) and 95% confidence intervals (CIs)
were calculated by univariate logistic regression analysis.
3. Results
A total of 112 patients who met the study criteria were
included in this study. PAD was present in 76.8% of the
patients. General demographics, laboratory results,
treatment outcomes, and the microbiological evaluation
results of the enrolled patients with (n = 86) and without
PAD (n = 26) are shown in Table 1. Among the study
patients, 75% of them were males and the mean age
was 61.4 (±10.9) years. When analyzed according to the
presence of PAD, it was observed that patients with PAD
were older than patients without PAD (mean age: 63.7 ±
10.0 vs 53.9 ± 10.6 years, respectively) (P < 0.000084). For
each unit increase in age, the PAD risk increased by 1.1fold (P = 0.002, OR: 1.1, 95% CI: 1.04–1.16).
During hospitalization 53.5% of patients received only
medical therapy, and in addition to this, 17.9% of them
underwent surgical debridement and 28.6% underwent
minor or major lower extremity amputation, as shown in
Table 1. Of the eight major amputations, five were below
the knee, one was above the knee, one was tibiotalar,
and one was transtibial. All 21 minor amputations were
phalanx amputations. When the PAD and the non-PAD
groups were compared in terms of treatment options, the
amputation rates were found to be higher in the PAD group
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(P = 0.029). Logistic regression analysis showed a 3.9-fold
difference (P = 0.039, OR: 3.9, 95% CI: 1.08–14.07). There
was no statistical difference between the amputation group
and nonamputation group in terms of age, sex, previous
amputation, osteomyelitis, previous DFI, ulcer duration,
or HbA1c.
Wound culture results of all patients were also evaluated
in this study, which revealed a total of 140 bacteria
identified in 112 patients (Table 2). Of these bacteria,
57.1% were gram-positive and 42.8% were gram-negative.
The most frequently isolated gram-positive bacteria were
S. aureus and Streptococcus spp. Methicillin resistance
was 17.2% in S. aureus strains and 37.5% in coagulasenegative staphylococci strains. The prevalence of MRSA
among all patients was 4.5%. Penicillin resistance was
detected in 18.2% of enterococcal strains. Vancomycinresistant enterococci were not detected in any of the
cultures. Escherichia coli and Pseudomonas spp. were the
most frequently encountered organisms among the gramnegative bacteria. ESBL positivity was calculated as 21.4%
in enteric gram-negative rods. No carbapenem resistance
was observed, except in one Acinetobacter strain.
Patients with and without PAD were compared in
terms of the four most frequently detected bacteria (S.
aureus, Streptococcus spp., E. coli, Pseudomonas spp.), as
shown in Table 1. Pseudomonas spp. were observed in 15
patients with PAD, whereas no Pseudomonas spp. were
detected in the wound cultures of any patient without
PAD. The difference was statistically significant (P = 0.02).
However, there were no significant differences between the
two groups for other bacteria.
MDR bacteria were detected in 27 of 112 patients
(24.1%). Of these bacteria, 51.8% were MDR gramnegative bacilli, 22.2% were methicillin-resistant
coagulase-negative staphylococci, 18.5% were MRSA, and
7.4% were MDR enterococci. When compared in terms of
MDR microorganisms, the incidence of resistant bacteria
in patients with PAD was higher than those without PAD
(30.2% and 7.6%, respectively). The difference was found
to be 4.9-fold when analyzed with logistic regression (P =
0.039, OR: 4.9, 95% CI: 1.08–22.3).
4. Discussion
In this study, we examined the frequency of PAD in
hospitalized patients with PEDIS infection scores of 3–4
and its effects on the clinical features, microbiology, and
treatment outcomes. We observed that DFI patients with
PAD were of older age, the presence of Pseudomonas spp.
infection and MDR bacterial infections was higher, and
DFIs were more likely to end with an amputation in the
PAD group.
PAD occurs in 20%–30% of all diabetic patients (7).
The incidence is much higher, ranging from 36% to 70%
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Table 1. Patients demographics, clinical features, and microbiological evaluation according to PAD presence.
PAD (+)
(n = 86, %)

PAD (-)
(n = 26, %)

Total
(n = 112, %)

P-value

Patient characteristics
Median age (min–max)

63.0 (41–85)

53.5 (28–79)

61.4 (28–85)

0.000084

Male

63 (73.3)

21 (80.8)

84 (75.0)

0.605

Antibiotic use in 6 months

57 (66.3)

18 (69.2)

75 (67.0)

0.966

Previous DFI

60 (69.8)

14 (53.8)

74 (66.1)

0.132

Previous amputation*

27 (31.4)

5 (19.2)

32 (28.6)

0.375

PEDIS infection score
Grade 3
Grade 4

71 (82.6)
15 (17.4)

22 (84.6)
4 (15.4)

93 (83.0)
19 (17.0)

1.000

Osteomyelitis

74 (86.0)

23 (88.5)

97 (86.6)

1.000

12.3 ± 4.8

11.4 ± 6.3

12.1 ± 5.2

0.095

Laboratory results*
White blood cell (×103/µL)
C-reactive protein (mg/L)

99.4 ± 99.6

88.0 ± 96.4

96.7 ± 98.6

0.417

Erythrocyte sedimentation rate (mm/h)

77.7 ± 28.1

75.1 ± 27.6

77.1 ± 27.9

0.670

HbA1c (%)

9.2 ± 2.4

9.9 ± 2.5

9.4 ± 2.4

0.297

45 (52.3)

15 (57.7)

60 (53.5)

0.630

Treatment outcomes
Only medical therapy
Debridement

12 (14.0)

8 (30.8)

20 (17.9)

0.076

Amputation
Minor
Major

29 (33.7)
21 (24.4)
8 (9.3)

3 (11.5)
3 (11.5)
0

32 (28.6)
24 (21.4)
8 (7.2)

0.029
-

Exitus

3 (3.5)

0

3 (2.6)

-

Monomicrobial
Polymicrobial

63 (73.2)
23 (26.8)

21(80.8)
5 (19.2)

84 (75.0)
28 (25.0)

0.438

Most frequent pathogens
S. aureus
Streptococcus spp.
E. coli
Pseudomonas spp.
MDR bacteria presence

19 (22.1)
16 (18.6)
14 (16.3)
15 (17.4)
25 (29.0)

10 (38.5)
4 (15.4)
2 (7.7)
0
2 (7.7)

29 (20.7)
20 (14.3)
16 (11.4)
15 (10.7)
27 (24.1)

0.125
1.000
0.353
0.020
0.019

Microbiological evaluation

*Data of two patients missing.

in diabetic patients with foot wounds (6,7,13,14). In this
study, the frequency of PAD was found to be 76.8%, which
is higher than that reported by several studies (6,7,13,14).
This can be attributed to our patient group, which included
only patients with severe DFIs requiring hospitalization
and did not include outpatients.
Several studies have reported that PAD occurs more
in elderly patients. In a study of 1002 patients diagnosed
with a new diabetic foot ulcer, PAD was found in 71% of
patients aged >70 years (13). In the Eurodiale study that
was performed prospectively with 1232 patients, the mean

age of the PAD group was significantly higher than that
of the non-PAD group (69 ± 11.2 vs. 60.5 ± 12.3 years,
respectively) (6). Similarly, in our study, the mean age was
significantly higher in the PAD group (63 ± 10.0 vs. 53.5 ±
10.6 years, respectively, P < 0.05)
In diabetic patients, the presence of PAD prevents the
healing of ulcers and increases the rate of amputation and
mortality (15). In the Eurodiale study, the rates of major
amputations and mortality were found to be significantly
higher in the PAD group (8% and 9%, respectively) than
in the non-PAD group (2% and 3%, respectively) (6).
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Table 2. Distribution of bacteria detected in the wound cultures
of patients.
Microorganisms

No.

%

Gram-positive bacteria (total)

80

57.1

Staphylococcus aureus

29

20.7

Streptococcus spp.

20

14.3

Coagulase-negative streptococci

16

11.4

Enterococcus spp.

11

7.9

Corynebacterium spp.

3

2.1

Micrococcus luteus

1

0.7

Gram-negative bacteria (total)

60

42.9

Escherichia coli

16

11.4

Pseudomonas spp.

15

10.7

Enterobacter spp.

8

5.7

Klebsiella spp.

6

4.3

Proteus spp.

5

3.6

Morganella morganii

2

1.4

Citrobacter spp.

2

1.4

Acinetobacter spp.

2

1.4

Other gram-negative bacteria

4

2.8

Total

140

100

Another study from Turkey reported a major amputation
rate of 28% and a minor amputation rate of 22% in
DFI patients and the authors also underlined the high
incidence of PAD (89%) in the amputation group (16). Yet
another study showed that patients who did not undergo
revascularization with peripheral angioplasty had worse
wound-healing processes and higher amputation rates
(17). Lipsky also emphasized that PAD and infection were
the two most important causes of amputation in diabetic
patients (18). The findings of our study are consistent
with these data, revealing that amputation rates were
significantly higher in the PAD group than in the nonPAD group (33.7% vs. 11.5% respectively, P < 0.05). We
could not find any significant relationship with age, sex,
osteomyelitis, previous amputation, previous DFI, ulcer
duration, or HbA1c. Poor glycemic control, peripheral
neuropathy, previous DFI, and ulcer depth and duration
have been reported as other independent risk factors for
amputation in the literature (19,20).
S. aureus, streptococci, gram-negative bacilli, and
anaerobic bacteria are the most frequently detected
pathogens in DFIs, and their prevalence may vary with
the duration and severity of infection, antibiotic use,
duration of hospitalization, presence of osteomyelitis,
and geographical area (3,21,22). Studies from Europe and

848

North America (23,24) have revealed that gram-positive
bacteria were the primarily isolated pathogens in DFIs,
whereas conversely, in Asian studies (25), the prevalence
rate of aerobic gram-negative bacteria has been reported to
be higher than that of gram-positive bacilli. This difference
may be due to culture sampling methods and inappropriate
antibiotic use, as well as cultural, geographical, and climatic
factors (26). Several studies in our country have reported
similar prevalence rates of gram-negative and -positive
bacteria, with a slight predominance of gram-negative ones
in DFIs (27). In our study, the prevalence rate of grampositive microorganisms was found to be higher than that
of gram-negative bacteria (57.1% vs. 42.9%, respectively),
which is similar to the data from Western countries. The
reason for the high prevalence rates of gram-negative
bacteria isolated in DFIs in our country is thought to be
associated more with the culture sampling methods rather
than regional differences. Regarding the pathogenesis of
DFIs, it is known that staphylococci and streptococci take
place at the beginning of the infection, followed by gramnegative bacilli as the infection stage progresses (7). This
becomes obvious when deep tissue cultures are obtained.
In our study, S. aureus was found to be the most
frequently isolated pathogen with a rate of 19.6% among
all isolates, followed by Streptococcus spp. (13.7%),
Pseudomonas spp. (12.4%), and E. coli (11.8%). S. aureus
has been reported to be the most common pathogen in
several studies as in our study (14). In addition, some other
studies have reported Pseudomonas spp. (28), E. coli (14),
enterococci (29), and coagulase-negative staphylococci
(30) as the most common pathogens in diabetic foot
wounds.
The prevalence of MRSA in all types of infections
has increased during the past few decades in Western
countries and has become an emerging problem. The
prevalence of MRSA in DFIs varies between 12% and
30% in several studies from Europe and the United States
(9,21,31). In our country, MRSA prevalence is not as high
as in Western countries. A large systematic review showed
that MRSA prevalence in DFIs was not in high levels and
had actually decreased in 2007–2011 compared to 1989–
2011 period (respectively 5.7% and 7.8%) (26). In this
study, the prevalence of MRSA in DFIs was 4.5%, which is
compatible with the data in Turkey.
The resistance rates of bacteria isolated from DFI
cultures are at substantial levels. In our study, MDR
bacteria were detected in nearly one-fourth of all patients.
Infection with MDR bacteria may cause a longer hospital
stay, higher treatment costs, and a worse outcome.
Patients with DFIs have several risk factors that lead to
MDR bacteria. Frequent hospitalization, previous broadspectrum antibiotic use, osteomyelitis, ulcer duration,
size and type (ischemic ulcer), and diabetes duration have
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been found to be associated with MDR bacteria in DFIs
(9,32,33). In this study, PAD was found to be associated
with MDR bacteria (P < 0.05). PAD may potentially lead to
the selection of resistant microorganisms by reducing the
transition rates of antibiotics to the tissue (34). However,
a considerable proportion of these patients with MDR
bacteria had frequent antibiotic use, previous DFI, and
osteomyelitis. Therefore, we believe that these underlying
conditions are the main contributing factors to bacterial
resistance.
We also compared the PAD and the non-PAD
groups in terms of the four most isolated pathogens, and
Pseudomonas spp. were found to be more frequent in the
PAD group (P = 0.02). There were no significant differences
in terms of other bacteria (S. aureus, Streptococcus spp.,
E. coli). We came across only one study in the literature
investigating the relationship between PAD and causative
microorganisms. In that study, the causative pathogens of
DFIs were assessed for the presence of ischemia, and no
difference was detected in terms of microorganisms (14).
Further investigation using larger patient groups is needed
on this subject. However, we believe that our finding may

be useful for clinicians dealing with the treatment of DFIs,
especially in the planning of empirical treatment.
In our study, we could not evaluate the prevalence
rate of anaerobic cultures and their effect on the patients’
clinical course because anaerobic tissue cultures are not
routinely applied in our hospital. This is an important
limitation as anaerobic bacteria are believed to have a
significant role in DFIs, especially in patients with PAD.
In conclusion, we found that PAD is very common
in patients with PEDIS grade 3–4 DFIs and its frequency
increases with age. The prevalence of MDR organisms and
Pseudomonas spp. is also elevated in this group. Medical
therapies and wound debridement procedures are not
always sufficient, and the need for amputation, which
is known to reduce the quality of life and shorten life
expectancy, is high. Therefore, PAD should be investigated
especially in elderly adults with DFIs, and medical and
surgical-vascular interventions should be performed
immediately to prevent lower extremity limb loss.
Clinicians should consider Pseudomonas spp. and MDR
bacteria in this group of patients and start therapy with
broad spectrum antipseudomonal antibiotics.
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